Complete your online assessment
Tell us about your health, your medications and what you want to change, all from home in Delaware. The questionnaire is short, there is nothing to schedule, and it works the same for everyone in Delaware.
Provider guided GLP-1 care
Personalized Compounded Tirzepatide in Delaware.
Bodi Envi connects adults in Delaware with licensed providers who can prescribe personalized compounded tirzepatide when it is the right fit. The assessment, the review and the follow up all happen online, and the medication arrives by delivery.
✓ LegitScript certified✓ Licensed providers✓ One price, every dose
How it works
Getting started in Delaware
Three steps, all online, from the first question to the delivery at your door.
A licensed provider reviews it
A licensed provider with Wasef Health, PC, the clinical organization for applicable Bodi Envi programs, reads your answers and decides whether personalized compounded tirzepatide is a safe and appropriate option for you.
Your prescription ships to you
When a provider prescribes, the prescription goes to VialsRx, the pharmacy partner for GLP-1 programs, which prepares it and sends it to your Delaware address.
Please note: a licensed provider determines whether treatment is appropriate. Treatment is not guaranteed. If a patient is not qualified, a refund will be issued.
Understanding personalized compounded tirzepatide
Tirzepatide is a dual GIP and GLP-1 receptor agonist. Where semaglutide works on one receptor, tirzepatide engages two, each tied to a hormone involved in fullness and blood sugar control. It is the medication at the center of Bodi Envi's Personalized Compounded Tirzepatide Weight-Management Programs for Delaware residents.
Personalized Compounded Tirzepatide is a version of that active ingredient prepared by a licensed compounding pharmacy from a prescription written for an individual patient. It is taken as a weekly injection, and the starting dose and any later change are decided by the prescribing provider, not by the patient and not by Bodi Envi.
Personalized Compounded Tirzepatide is not FDA-approved and is not equivalent to the FDA-approved products that contain the same active ingredient, Mounjaro® and Zepbound®. The FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed, which is why a licensed provider decides case by case whether treatment is appropriate. Brand names are trademarks of their respective owners. Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.
Pricing
Personalized Compounded Tirzepatide pricing for Delaware residents
Pricing does not change by location, so Delaware residents see the same four plans as the rest of the country. Pay month to month or prepay a longer term for a lower monthly equivalent. The dose your provider sets does not change what you pay.
Monthly
$229/ month
Billed monthly
3 months
$219/ month
$657 paid once
6 months
$205/ month
$1,230 paid once
12 months
$175/ month
$2,100 paid once
For applicable programs, pricing does not increase based solely on dosage strength. Medication is included only when a licensed healthcare provider determines treatment is medically appropriate and issues a prescription. Current pricing and plan details are on the Plans page.
What is included
- Online health assessment and review by a licensed provider
- Personalized Compounded Tirzepatide when a provider determines it is appropriate
- Ongoing care team messaging and treatment monitoring
- Dispensing and delivery by a licensed pharmacy partner
- One price regardless of dose strength
Available across Delaware
The program reaches every part of Delaware. From Wilmington, Dover, Newark, Middletown, Smyrna and Milford to rural counties, the steps are identical: an online health assessment, a licensed provider's decision, and delivery from the pharmacy partner to a valid Delaware address.
How pharmacies serving Delaware are regulated
The Delaware Board of Pharmacy is the Delaware agency responsible for licensing and inspecting pharmacies that serve patients in the state. When personalized compounded tirzepatide is prescribed, a licensed compounding pharmacy prepares it for that patient specifically. Bodi Envi is not a pharmacy, not a medical practice and not a manufacturer, and it does not compound medications. Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards. Delaware Board of Pharmacy.
Read more
Why online care works in Delaware
For people in Delaware, telehealth means the assessment fits around your day instead of the other way round. From Dover to Newark, patients share their health history online, hear back from a licensed provider, and stay in touch with the care team by secure message. If treatment with personalized compounded tirzepatide is appropriate, the pharmacy partner delivers it to your door in Delaware. There is no Delaware office because none is needed.
Questions
Personalized Compounded Tirzepatide in Delaware
Straight answers about eligibility, pricing and how the program works where you live.
Yes. Bodi Envi connects eligible adults in Delaware with licensed healthcare providers who can prescribe personalized compounded tirzepatide when it is clinically appropriate. If prescribed, the medication is dispensed by a licensed pharmacy partner and shipped to your Delaware address. Compounded medications are not FDA-approved.
Published pricing is the same for Delaware residents as for everyone else. The same four plans apply in Delaware as everywhere else: $229 a month on monthly billing, $219 a month on the 3-month term, $205 a month on the 6-month term and $175 a month on the 12-month term. Pricing does not increase based solely on dosage strength. Current pricing is always on the /pricing page.
No in person visit is required. The health assessment is completed online, a licensed provider with Wasef Health, PC reviews it, and in most states the treatment plan reaches you through online questionnaire and secure chat. There is no office to travel to in Delaware.
Licensed healthcare providers independently evaluate each Delaware patient and decide whether treatment is medically appropriate. Wasef Health, PC is the clinical provider organization for applicable Bodi Envi programs, with Michael Wasef, MD as Medical Director.
VialsRx is Bodi Envi's current pharmacy partner for GLP-1 prescriptions, including those written for Delaware patients. Pharmacy partners dispense and fulfill prescriptions when a licensed provider prescribes, and ship to your Delaware address. Pharmacy availability may vary by program and patient location.
It is not. Mounjaro® and Zepbound® are FDA-approved products; personalized compounded tirzepatide is a compounded medication, which the FDA does not review for safety, effectiveness or quality before it is marketed, and which is not equivalent to those products. Brand names are trademarks of their respective owners. Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.
It is. LegitScript certification is shown in the footer of every Bodi Envi page, and the badge links to LegitScript's own record so you can check it for yourself.
Yes. Both personalized compounded semaglutide and personalized compounded tirzepatide programs are available to eligible adults in Delaware, along with micro-dose versions of each. A provider with Wasef Health, PC recommends the option that fits your health history and goals.
A micro-dose program for tirzepatide exists and is open to eligible adults in Delaware. You do not choose the dose yourself: after the assessment, a licensed provider with Wasef Health, PC determines the dosing approach that is appropriate, if any.
The next step belongs to the licensed provider with Wasef Health, PC, who reads your assessment and determines whether treatment is appropriate. Treatment is not guaranteed. If a patient is not qualified, a refund will be issued. If personalized compounded tirzepatide is prescribed, the pharmacy partner fills the prescription and ships it to your Delaware address, and ongoing monitoring happens through the care team.
Important information about compounded medications
Personalized compounded semaglutide and personalized compounded tirzepatide are not FDA-approved and are not equivalent to FDA-approved products.
The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed.
Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.
Treatment is not guaranteed. A licensed healthcare provider determines whether treatment is appropriate for each individual patient. Individual experiences and outcomes vary. If a patient is not qualified, a refund will be issued.
Bodi Envi is not a medical practice, pharmacy, or medication manufacturer. Brand names are trademarks of their respective owners.
Ready when you are
Start your personalized compounded tirzepatide assessment in Delaware
Answer the health questions online and let a licensed provider decide whether personalized compounded tirzepatide fits. If it does, your medication is delivered to your Delaware address. Treatment is not guaranteed, and Delaware residents pay the same published price at every dose. If a patient is not qualified, a refund will be issued.